Clinical Trial Update: Antifungal Therapy for Fever and Neutropenia in Patients Receiving Treatment for Hematologic Cancer [Phase 3]

View source ↗

Summary

A completed Phase 3 trial evaluating an antifungal therapy for fever and neutropenia in patients undergoing treatment for hematologic cancers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infection
• Leukemia
• Lymphoma
• Multiple Myeloma and Plasma Cell Neoplasms
• Myelodysplastic Syndromes
• Myeloproliferative Neoplasms

Drugs mentioned

• Antifungal therapy (Phase 3 trial)

Snippet

Sponsor: Aronex Pharmaceuticals | Conditions: Chronic Myeloproliferative Disorders, Infection | Phase 3 | Status: COMPLETED